12/18/2024 4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/13/2024 4:15 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/09/2024 4:29 PM | Virpax Pharmaceuticals (Filer)
| Form DEF 14A | |
11/29/2024 5:39 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/26/2024 4:01 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2024 3:31 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/20/2024 5:06 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
11/15/2024 4:20 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/12/2024 11:15 PM | Virpax Pharmaceuticals (Filer)
| Form EFFECT | |
11/07/2024 4:01 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
10/28/2024 3:08 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
10/18/2024 4:28 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
10/10/2024 4:07 PM | Virpax Pharmaceuticals (Filer)
| Form 10-K/A | |
10/10/2024 4:08 PM | Virpax Pharmaceuticals (Filer)
| Form 10-K/A | |
10/09/2024 4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K/A | |
10/04/2024 3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2024 3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2024 3:12 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 8:05 AM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
08/13/2024 6:35 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/30/2024 4:26 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/29/2024 3:30 PM | Virpax Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
07/26/2024 3:31 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2024 6:45 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/15/2024 5:40 PM | Su Judy (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/15/2024 7:00 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2024 3:09 PM | Field Katharyn (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/10/2024 3:10 PM | Field Katharyn (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 11:48 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/09/2024 3:00 PM | Dhaliwal Jatinder (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/09/2024 3:01 PM | Herman Gary L (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/09/2024 3:02 PM | Dhaliwal Jatinder (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/09/2024 3:03 PM | Herman Gary L (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/08/2024 3:32 PM | Virpax Pharmaceuticals (Filer)
| Form DEFA14A | |
07/08/2024 6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2024 4:09 PM | Virpax Pharmaceuticals (Filer)
| Form DEF 14A | |
06/12/2024 4:11 PM | Virpax Pharmaceuticals (Filer)
| Form ARS | |
05/14/2024 11:15 PM | Virpax Pharmaceuticals (Filer)
| Form EFFECT | |
05/13/2024 4:30 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
05/13/2024 3:02 PM | Virpax Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/01/2024 8:54 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
This is the worst sign for the U.S. stock market in 50 years (Ad) The Dow recently posted its worst losing streak since 1974.
And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression.
Introducing "The Dead Zone" Click here to see Dan's new, urgent warning about the U.S. market for 2025. |
04/30/2024 6:35 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2024 4:15 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
04/18/2024 3:17 PM | Virpax Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
03/26/2024 7:15 AM | Virpax Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 5:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 5:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 3:05 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/31/2024 3:22 PM | Floyd Eric (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:22 PM | Bruce Gerald W (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:23 PM | Sendrow Jerrold (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:23 PM | Dubin Michael F (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:24 PM | Mathias Sheila (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:25 PM | Jambulingam Thani (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:25 PM | Shah Vinay (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:26 PM | Singh Vanila (Reporting) Virpax Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 9:11 AM | SABBY MANAGEMENT, LLC (Filed by) Virpax Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/29/2023 6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |